0HF3

AmerisourceBergen Corp.

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Distributeur pharmaceutique fournissant des services logistiques et gestion de la chaîne d'approvisionnement pour les produits de santé et médicaments.

£ 3.56
0.40 %

AmerisourceBergen Corp.

£ 3.56
0.40 %
0HF3

Distributeur pharmaceutique fournissant des services logistiques et gestion de la chaîne d'approvisionnement pour les produits de santé et médicaments.

Price history of AmerisourceBergen Corp.
Price history of AmerisourceBergen Corp.

Performance & Momentum

6 Months 21.42 %
1 Year 42.24 %
3 Years 135.38 %
5 Years 229.20 %

Strategic Analysis

AmerisourceBergen Corp. • 2026

AmerisourceBergen is positioned as a key player in pharmaceutical distribution in the United States, offering advanced logistics services and optimized supply chain management for healthcare products. Its specialization in the medical supply chain gives it a competitive advantage in a fast-growing sector tied to evolving healthcare needs.

Strengths
  • Robust logistics network and effective vertical integration
  • Dominant position in a large and fragmented U.S. market
  • Ability to meet the complex requirements of pharmaceutical supply chains
Weaknesses
  • High dependence on the North American market, limiting geographic diversification
  • Exposure to strict regulations and margin pressures in the healthcare sector
Momentum

Momentum is particularly strong, supported by steady growth over several years and recent solid performance. This trajectory reflects increased investor confidence, reinforcing the outlook for sustained growth in a context of high demand for pharmaceutical distribution services.

Similar stocks to AmerisourceBergen Corp.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone